0 إشارة هذا الأسبوع
0
اجتماعي
أخبار
مدونة
Bristol Myers Squibb to buy RayzeBio in $4.1 billion cash deal
قبل ٦ي
mRNA melanoma vaccine cuts recurrence risk by 44% in interim Phase 3 data
